Marvin Slepian, MD, compares the hemocompatibility of Impella 5.5 to Centrimag discussing hemolysis, platelet activation, microparticle generation, and vWF alteration.
Learn when and how to use echocardiography to visualize in real-time the relationship of the Impella 5.5 with SmartAssist to structures within the left ventricle.
Yoshiki Sawa, MD, PhD, discusses a large multicenter study in Japan demonstrating high survival rates in AMI cardiogenic shock patients receiving the Impella heart pump.
Three intensivists discuss managing Impella patients in the CCU, focusing on weaning off inotropes, repositioning Impella, invasive monitoring, and use of Impella and ECMO.
Three physicians from the Cleveland Clinic discuss strategies for selecting the Impella® heart pump and/or ECMO as well as patient management and venting strategies.
Alexander Truesdell, MD, discusses best practices based on his team’s real-world experience treating cardiogenic shock.
NPS-1674
This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].
The Protected PCI community
is now on HeartRecovery.com
Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
